Unusual susceptibility to vancomycin in Elizabethkingia meningoseptica: mechanisms and clinical implications
Abstract
Elizabethkingia meningoseptica, an environmental, non-fermenting Gram-negative bacillus, poses a serious clinical challenge due to its intrinsic multidrug resistance. Paradoxically, the pathogen exhibits exceptional in vitro susceptibility to vancomycin, a glycopeptide antibiotic normally directed only against Gram-positive organisms. This review systematically synthesizes recent evidence-published since earlier key reviews-on this paradoxical susceptibility. The review clarifies taxonomic evolution and identification challenges within the genus Elizabethkingia, highlighting how frequent misidentification between E. meningoseptica and E. anophelis has confounded historical susceptibility data. It proceeds to critically evaluate methodological variations in antimicrobial susceptibility testing and their impact on vancomycin susceptibility reporting. It discusses emerging mechanistic insights, including hypothesized increased outer-membrane permeability and biofilm inhibition at sub-minimum inhibitory concentrations, as plausible but not yet conclusively proven explanations for vancomycin activity. Finally, it proposes evidence-based treatment strategies, emphasizing susceptibility-guided combination regimens over vancomycin monotherapy. This updated synthesis aims to provide both theoretical grounding and pragmatic clinical guidance for managing multidrug-resistant Elizabethkingia infections.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.